Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 23

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 23
---
964 |   |
| Total long-term debt                                                                                                                                                                                   |     |                                                |   14,863 |   |     |             |   14,863 |   |
| Ordinary Shares of no par value: 362,116,800 shares authorized, 70,380,570 shares issued and outstanding, actual; 362,116,800 shares authorized, 84,490,691 shares issued and outstanding, as adjusted |     |                                                |        - |   |     |             |        - |   |
| Additional paid-in capital                                                                                                                                                                             |     |                                                |  210,175 |   |     |             |  246,910 |   |
| Accumulated deficit                                                                                                                                                                                    |     |                                                | (147,509 | ) |     |             | (147,509 | ) |
| Total shareholders’ equity                                                                                                                                                                             |     | $                                              |   62,666 |   |     | $           |   99,401 |   |
| Total capitalization                                                                                                                                                                                   |     | $                                              |   77,529 |   |     | $           |  114,264 |   |

As adjusted shareholders’ equity amounts
shown in the table above exclude the impact of:

| ● | 5,391,284 ordinary shares issuable upon the exercise of options                                                                  
 outstanding as of December 31, 2024 under our 2016 Share Incentive Plan at a weighted-average exercise price of $5.00 per share; |

| ● | 9,058,366 ordinary shares issuable upon the exercise of options                                                                  
 outstanding as of December 31, 2024 under our 2021 Share Incentive Plan at a weighted-average exercise price of $4.39 per share; |

| ● | 857,899 ordinary shares issuable upon the vesting of RSUs 
 outstanding as of December 31, 2024;                      |

| ● | 15,747,561 ordinary shares issuable upon the exercise of warrants                             
 outstanding as of December 31, 2024 at a weighted-average exercise price of $11.50 per share; |

| ● | 11,383,655 ordinary shares reserved for future issuance under 
 our 2021 Share Incentive Plan as of December 31, 2024; and    |

| ● | 2,673,455 ordinary shares reserved for future issuance under   
 our 2021 Employee Share Purchase Plan as of December 31, 2024.